ORCHARD THERAPEUTICS PLC Deferred Revenue
ORCHARD THERAPEUTICS PLC had Deferred Revenue of $742.00 thousand as of 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DeferredRevenueCurrent · last filed 2023-11-13
- 2023-09-30: Deferred Revenue, Current $742.00K.
- 2023-06-30: Deferred Revenue, Current $752.00K.
- 2023-03-31: Deferred Revenue, Current $634.00K.
- 2022-12-31: Deferred Revenue, Current $959.00K.
| Period end | Deferred Revenue, Current |
|---|---|
| 2023-09-30 | $742.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $752.00K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $634.00K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $959.00K 10-Q · filed 2023-11-13 |
| 2022-09-30 | $1.38M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $1.15M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $889.00K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $346.00K 10-K · filed 2023-03-14 |
| 2021-09-30 | $1.39M 10-Q · filed 2021-11-04 |